Two Sigma Ventures’ Post

Two Sigma Ventures reposted this

View organization page for Terray Therapeutics, graphic

4,957 followers

Thank you to Steve Lohr and The New York Times for featuring Terray Therapeutics. We’re proud to be changing the way computation and experimentation work together to generate the kind of data needed to deliver on the promise of A.I. in drug discovery to solve the toughest therapeutic challenges. As our CEO, Jacob Berlin, PhD said: “Once you have the right kind of data, the A.I. can work and get really, really good.” That is our data, and it's all pointed at a “once-in-a-century opportunity" for the pharmaceutical industry to deliver for patients in need. Thank you to our extraordinary team, our partners at Bristol Myers Squibb and Calico Life Sciences, our collaborators at NVIDIA, and all of our amazing investors including Madrona, Digitalis Ventures, Two Sigma Ventures, and KdT Ventures.   The best is ahead. Read more: https://lnkd.in/eMtyFdNQ   #generativeAI #biotech #ML #drugdiscovery

How A.I. Is Revolutionizing Drug Development

How A.I. Is Revolutionizing Drug Development

https://www.nytimes.com

Mitchell Creasey

🎤TV Personality + Contributor 🏆Award Winning Executive Coach 📱mitch@mitchellcreasey.com Inquiries Stress Management Expert

1mo

Just read the article. What a revolutionary mission. Love the focus on inflammatory disease + the AI translation model being open source. #badass😎 wish I had a crystal ball to see just how much the clinical success rate goes up in the next 10 🙌

Like
Reply
Philip Cheung

Impacting Patient's Lives at the intersection of Bioinformatics, Data Sciences, and Scientific Software Development

1mo

Awesome!

Like
Reply
See more comments

To view or add a comment, sign in

Explore topics